NovaBay Pharmaceuticals Announces Significant Orders for DERMAdoctor's Top-Selling Kakadu C Anti-Aging Serum ahead of the Holiday Season
businesswire.com
news
2022-10-18 00:00:00

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces significant orders for DERMAdoctor® Kakadu® C 20% Vitamin C Serum with Ferulic Acid & Vitamin E.

'We are excited to share that one of our best-selling products, DERMAdoctor Kakadu C serum, continues its popularity this year with several large orders just in time for the holiday season,' said Justin Hall, NovaBay CEO. 'These orders will favorably impact DERMAdoctor's revenue contribution for the 2022 third and fourth quarters.
